Perbedaan Saranacentral Bajatama Tbk dan Merck Tbk.: Saranacentral Bajatama Tbk diperdagangkan di Rp161 (kapitalisasi pasar 288 M, volume 24 jam 1,21 jt), sedangkan Merck Tbk. diperdagangkan di Rp3.740 (kapitalisasi pasar 1,68 T, volume 24 jam 22,8 rb). Perbedaan utamanya: Merck Tbk. jauh lebih besar — sekitar 5,8× kapitalisasi pasar Saranacentral Bajatama Tbk, dan Saranacentral Bajatama Tbk lebih aktif diperdagangkan (1,21 jt vs 22,8 rb). Mana yang lebih baik tergantung tujuan investasimu.
| BAJA | MERK | |
|---|---|---|
Kapitalisasi Pasar | 288 M | 1,68 T |
Volume | 1,21 jt | 22,8 rb |
Lot | 12,09 rb | 228 |
Perputaran | 193,62 jt | 82,9 jt |
Harga Rata-rata | 160,18 | 3.636,14 |
Nilai Transaksi | 193,62 jt | 82,9 jt |
Harga Ekuilibrium Indikatif | 161 | 3.520 |
Volume Ekuilibrium Indikatif | 4 | 60 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Saranacentral Bajatama (SCB), established in 1996, is belonging to Sarana Steel Group, which was set up in 1970 and has built up its strong reputation in the worldwide steel industry. In order to provide competitive Hot-Dip Galvanized Steel Sheet/Coil to the customers, SCB take advantage of more advanced NOF (Non-Oxidation Furnace) System for production process, by which SCB differentiate itself from other competitors that use conventional processing system.
Selengkapnya di halaman BAJA →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →